24 phenotypes from 6 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Plntm1Egk/Plntm1Egk involves: 129S2/SvPas	abnormal cardiac muscle relaxation	J:106044
	abnormal myocardial fiber physiology	J:106044
	atrial fibrillation	J:212640
	increased cardiac muscle contractility	J:106044
Plntm1Egk/Plntm1Egk involves: 129S2/SvPas * CF-1	abnormal heart left ventricle pressure	J:39745
	increased cardiac muscle contractility	J:39745, J:59967
Plntm1Egk/Plntm1Egk involves: 129S2/SvPas * CF-1 * FVB/N	increased heart weight	J:134706
Plntm1Egk/Plntm1Egk Tg(Myh6-Pln)1Egk/? involves: 129S2/SvPas	normal cardiovascular system phenotype	J:66084
Plntm1Egk/Plntm1Egk Tg(Myh6-Pln)11Egk/? involves: 129S2/SvPas	abnormal cardiac muscle contractility	J:66084
	abnormal myocardial fiber physiology	J:66084
Plntm1Egk/Plntm1Egk Tg(Myh6-Pln)22Egk/? involves: 129S2/SvPas	normal cardiovascular system phenotype	J:66084
Tg(Myh6-Pln)416Egk/? FVB/N-Tg(Myh6-Pln)416Egk	abnormal cardiac muscle contractility	J:135899
	abnormal myocardial fiber physiology	J:135899
Tg(Myh7-Pln)2Egk/0 FVB/N-Tg(Myh7-Pln)2Egk	abnormal muscle physiology	J:224766
	abnormal skeletal muscle fiber morphology	J:224766
	abnormal skeletal muscle fiber type ratio	J:224766
	centrally nucleated skeletal muscle fibers	J:224766
	decreased soleus weight	J:224766
	impaired exercise endurance	J:224766
	impaired skeletal muscle contractility	J:94077
	increased creatine kinase activity	J:224766
	muscle weakness	J:224766
	myopathy	J:224766
	oxidative stress	J:224766
	skeletal muscle atrophy	J:94077, J:224766
	skeletal muscle endomysial fibrosis	J:224766
	skeletal muscle fibrosis	J:224766
Tg(Myh7-Pln)2Egk/? involves: FVB/N	abnormal skeletal muscle fiber type ratio	J:127873
	abnormal soleus morphology	J:127873
	impaired muscle relaxation	J:127873
	impaired skeletal muscle contractility	J:127873